0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

CLINICAL NOTES   |    
TREATMENT OF SEVERE DEPRESSION WITH DESIPRAMINE, A METABOLITE OF IMIPRAMINE
ADAM J. KRAKOWSKI
Am J Psychiatry 1963;120:494-496.
View Author and Article Information

Champlain Valley and Physicians Hospitals, Plattsburgh, N. Y.

text A A A
PDF of the full text article.
Abstract

Desipramine, an active metabolite of imipramine, was administered to 129 patients with severe depressive disorders. The majority had a history of 1 to 4 depressive attacks. In most cases, the drug was given for 2 to 4 months in daily doses of 75 or 100 mg. (i.m.) for a few days, followed by 100 to 150 mg. orally, thereafter. Tranquilizers were given concurrently as required to control agitation, anxiety or insomnia.Desipramine produced a satisfactory clinical response in 99 (76.4%) patients. Compared to imipramine, used in previous studies, the new drug seems to be slightly more potent on a dose-size basis; it has a faster onset of action, evident in 2 to 7 days, and side effects appear to be milder and of shorter duration.Because of its rapid onset of action and mild side effects, desipramine may prove particularly useful in reducing the need for prolonged hospitalization in severe depressive conditions.

Abstract Teaser
Figures in this Article

Your Session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

+

References

+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Web of Science® Times Cited: 15

Related Content
Articles
Books
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 26.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 12.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 12.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 26.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 12.  >
Topic Collections
Psychiatric News
APA Guidelines
PubMed Articles